Search

everythinglearnresearchcommunity

for

Search:↓

Tamsulosin for enlarged prostate may increase the risk of severe low blood pressure, especially when starting or restarting the medication.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Finasteride may improve prostate cancer treatment outcomes.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

A new score can help predict which patients might have trouble urinating after prostate surgery.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

The normal human prostate does not significantly affect blood DHT levels.

Tamsulosin's sulfonamide group may contribute to floppy iris syndrome.

Finasteride safely treats enlarged prostate and male-pattern baldness.

Male pattern baldness may be linked to prostate cancer risk.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

Dihydroartemisinin helps reduce prostate enlargement in rats by stopping the growth of prostate cells.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Drugs for prostate enlargement and hair loss were not linked to increased risk of depression or suicide.

Older men with lower levels of available testosterone are more likely to be frail.

The journal retracted an article due to inaccurate statistics and asked the authors to revise and resubmit it.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Finasteride may reduce prostate bleeding by lowering blood vessel growth factor levels and blood vessel density in certain prostate areas.

Hair loss linked to prostate enlargement; stress and family history important factors.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Medical castration in prostate cancer patients can increase the risk of serious heart rhythm problems, so it's important to monitor heart activity during treatment.

Dutasteride may help shrink prostate cancer tumors.

Antiandrogens might help prevent or treat COVID-19 by blocking the virus's entry into cells.

Minoxidil can reduce functions related to androgen receptors.